BCM
JAZZ icon

Brown Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Brown Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,739
Closed -$209K – 135
2024
Q1 		$209K Sell
1,739
-37
-2% -$4.53K ﹤0.01% 133
2023
Q4 		$218K Sell
1,776
-40
-2% -$4.99K ﹤0.01% 128
2023
Q3 		$235K Hold
1,816
– – ﹤0.01% 122
2023
Q2 		$225K Sell
1,816
-44
-2% -$5.92K ﹤0.01% 125
2023
Q1 		$272K Sell
1,860
-11
-0.6% -$1.63K ﹤0.01% 121
2022
Q4 		$298K Sell
1,871
-85
-4% -$12.5K ﹤0.01% 120
2022
Q3 		$261K Hold
1,956
– – ﹤0.01% 118
2022
Q2 		$305K Hold
1,956
– – ﹤0.01% 113
2022
Q1 		$304K Buy
1,956
+71
+4% +$10.3K ﹤0.01% 119
2021
Q4 		$240K Hold
1,885
– – ﹤0.01% 122
2021
Q3 		$245K Sell
1,885
-1,831
-49% -$277K ﹤0.01% 123
2021
Q2 		$660K Sell
3,716
-100
-3% -$17.3K 0.01% 102
2021
Q1 		$627K Sell
3,816
-623
-14% -$103K ﹤0.01% 102
2020
Q4 		$733K Sell
4,439
-40
-0.9% -$5.96K 0.01% 99
2020
Q3 		$639K Sell
4,479
-155
-3% -$19.2K 0.01% 94
2020
Q2 		$511K Sell
4,634
-124
-3% -$13.7K ﹤0.01% 100
2020
Q1 		$475K Sell
4,758
-1,785
-27% -$231K 0.01% 95
2019
Q4 		$977K Sell
6,543
-56
-0.8% -$7.62K 0.01% 87
2019
Q3 		$846K Buy
6,599
+56
+0.9% +$7.51K 0.01% 90
2019
Q2 		$933K Sell
6,543
-111
-2% -$14.9K 0.01% 90
2019
Q1 		$951K Buy
6,654
+123
+2% +$16K 0.01% 87
2018
Q4 		$810K Buy
6,531
+109
+2% +$16.2K 0.01% 80
2018
Q3 		$1.08M Buy
6,422
+52
+0.8% +$8.94K 0.01% 78
2018
Q2 		$1.1M Buy
6,370
+35
+0.6% +$5.72K 0.01% 75
2018
Q1 		$957K Sell
6,335
-53
-0.8% -$7.78K 0.01% 82
2017
Q4 		$860K Sell
6,388
-239
-4% -$33.1K 0.01% 84
2017
Q3 		$969K Sell
6,627
-380
-5% -$57.5K 0.01% 84
2017
Q2 		$1.09M Buy
7,007
+91
+1% +$13.9K 0.01% 84
2017
Q1 		$1M Buy
6,916
+2,247
+48% +$293K 0.01% 87
2016
Q4 		$509K Sell
4,669
-15,142
-76% -$1.69M 0.01% 111
2016
Q3 		$2.41M Sell
19,811
-3,943
-17% -$531K 0.04% 89
2016
Q2 		$3.36M Buy
23,754
+162
+0.7% +$23.9K 0.05% 80
2016
Q1 		$3.08M Sell
23,592
-47,904
-67% -$5.96M 0.05% 84
2015
Q4 		$10M Buy
71,496
+1,076
+2% +$149K 0.16% 57
2015
Q3 		$9.35M Buy
70,420
+14,705
+26% +$2.53M 0.16% 59
2015
Q2 		$9.81M Sell
55,715
-4,745
-8% -$852K 0.16% 65
2015
Q1 		$10.4M Sell
60,460
-3,430
-5% -$589K 0.17% 62
2014
Q4 		$10.5M Sell
63,890
-204
-0.3% -$33.9K 0.18% 59
2014
Q3 		$10.3M Sell
64,094
-42,323
-40% -$6.51M 0.18% 61
2014
Q2 		$15.6M Buy
106,417
+17,840
+20% +$2.47M 0.26% 54
2014
Q1 		$12.3M Buy
88,577
+4,230
+5% +$637K 0.2% 58
2013
Q4 		$10.7M Buy
+84,347
New +$8.73M 0.17% 60

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Brown Capital Management's JAZZ Position: Q2 2024 in Review

Brown Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 1,739 shares — an estimated $209K sold.

Brown Capital Management first reported a position in JAZZ in Q4 2013 and held it in 42 quarters. The position peaked at $15.6M in Q2 2014. 455 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

  • Brown Capital Management reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Brown Capital Management sold 1,739 Jazz Pharmaceuticals shares in Q2 2024, an estimated $209K.
  • Brown Capital Management first reported a position in Jazz Pharmaceuticals in Q4 2013 and held it in 42 quarters.
  • Brown Capital Management's Jazz Pharmaceuticals position peaked at $15.6M in Q2 2014.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on Brown Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.